Search Results
Aug 28, 2026, 10:20 ET SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of High Roller Technologies, Inc. (NYSEAM: ROLR)
FloorNew York, NY [email protected]Tel: (212) 363-7500Fax: (212) 363-7171
More news about: Levi & Korsinsky, LLP
Aug 28, 2026, 08:00 ET BioLineRx Announces $3.75 Million Registered Direct Offering and Concurrent Private Placement
TEL AVIV, Israel, Aug. 28, 2026 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX) ("BioLineRx" or the "Company"), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases,
More news about: BioLineRx Ltd.
Aug 28, 2026, 05:32 ET La Food and Drug Administration statunitense ha accettato la domanda di autorizzazione per un nuovo farmaco denominato "K-911", destinato a pazienti affetti da glaucoma e ipertensione oculare
oculare.Contatto per i media:Kowa Company, Ltd.Dipartimento delle relazioni pubbliche (richieste solo per il Giappone)Tel.: +81-3-3279-7392
More news about: Kowa Company Ltd.
Aug 28, 2026, 04:14 ET La demande d'autorisation de mise sur le marché du « K-911 », destiné aux patients atteints de glaucome et d'hypertension oculaire, a été acceptée par la Food and Drug Administration (FDA) aux États-Unis
oculaire.Relations avec les médias :Kowa Company, S.A.S.Service des relations publiques (demandes en japonais uniquement)Tél. : +81-3-3279-7392
More news about: Kowa Company Ltd.
Aug 28, 2026, 01:03 ET Zulassungsantrag für „K-911" zur Behandlung von Patienten mit Glaukom und okulärer Hypertonie von der U.S. Food and Drug Administration zur Prüfung angenommen
Hypertonie anbieten.Medienkontakt:Kowa Company, Ltd.Abteilung für Öffentlichkeitsarbeit (nur Anfragen auf Japanisch)Tel.: +81-3-3279-7392
More news about: Kowa Company Ltd.
Aug 28, 2026, 01:01 ET La rapida adozione sul mercato di Viso Now segnala un cambiamento epocale nel modo in cui vengono sviluppate le applicazioni di visione artificiale
JamiesonVicepresidente, [email protected]Tel.: 07801 211 910
More news about: viso.ai
Aug 28, 2026, 01:01 ET Die rasche Marktakzeptanz von „Viso Now" signalisiert einen grundlegenden Wandel in der Art und Weise, wie Computer-Vision-Anwendungen entwickelt werden
JamiesonBereichsleiterin [email protected]Tel.: 07801 211 910
More news about: viso.ai
Aug 27, 2026, 20:47 ET WSE Investors Have Opportunity to Lead Wise Group plc Securities Fraud Lawsuit Filed by The Rosen Law Firm
Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827
More news about: THE ROSEN LAW FIRM, P. A.
Aug 27, 2026, 20:11 ET SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit
Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827
More news about: THE ROSEN LAW FIRM, P. A.
Aug 27, 2026, 20:00 ET AusperBio Completes $120 Million Series C Financing to Advance AHB-137 Toward Potential Commercialization and Expand Next-Generation HBV Therapies
ContactEmail: [email protected] ContactTel: 650-888-1756 (US)Email: [email protected]
More news about: AusperBio Therapeutics Inc.
Aug 27, 2026, 19:19 ET Au Royaume-Uni, le NICE publie des recommandations préconisant le financement systématique par le NHS du système de perfusion hypothermique oxygénée VitaSmart™ de Bridge to Life
depuis plus d'une décennie, démontrant ainsi son intérêt pour la thérapie par perfusion dans toute la région. La validation par un organisme reconnu tel que le NICE renforce encore davantage la confiance dans les avantages cliniques et économiques du programme HOPE, alors que les médecins américains découvrent
More news about: Bridge to Life, Ltd.
Aug 27, 2026, 19:18 ET SMPL Investors Have Opportunity to Lead The Simply Good Foods Company Securities Fraud Lawsuit
Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827
More news about: THE ROSEN LAW FIRM, P. A.
Aug 27, 2026, 19:17 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Noble Corporation plc - NE
share, or 9.07%, to close at $39.20 per share on July 28, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Aug 27, 2026, 19:11 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Metropolitan Bank Holding Corp.- MCB
share, or 8.96%, to close at $90.19 per share on July 22, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Aug 27, 2026, 19:11 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of VenHub Global, Inc. - VHUB
news, VenHub's stock price fell sharply, damaging investors.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Aug 27, 2026, 19:11 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rollins, Inc. - ROL
share, or 9.27%, to close at $39.44 per share on July 23, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Aug 27, 2026, 19:11 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alphabet Inc. - GOOG
share, or 6.89%, to close at $318.34 per share on July 23, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Aug 27, 2026, 18:43 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Coastal Financial Corporation - CCB
share, or 43.52%, to close at $39.91 per share on July 30, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Aug 27, 2026, 18:36 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Albertsons Companies, Inc. - ACI
share, or 21.63%, to close at $11.27 per share on July 23, 2025.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Aug 27, 2026, 18:31 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Carrier Global Corporation - CARR
share, or 8.9%, to close at $63.16 per share on July 28, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Aug 27, 2026, 18:31 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Yum! Brands, Inc. - YUM
share, or 2.92%, to close at $148.80 per share on August 3, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Aug 27, 2026, 18:30 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
share, or 38.32%, to close at $6.58 per share on July 30, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Aug 27, 2026, 18:29 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Olin Corporation - OLN
share, or 16.51%, to close at $18.51 per share on July 31, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Aug 27, 2026, 18:26 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI
share, or 21.45%, to close at $7.47 per share on July 20, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Aug 27, 2026, 18:25 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pegasystems Inc. - PEGA
share, or 16%, to close at $25.99 per share on July 22, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP